We are revolutionising cardiac health with our advanced AI-driven ECG patch technology. Our mission is to provide accurate, real-time heart monitoring to empower individuals and medical professionals in early detection and management of cardiac conditions. By combining cutting-edge artificial intelligence with state-of-the-art wearable technology, we ensure precise diagnostics and a seamless user experience. Trust FibriArt to redefine how we monitor and care for heart health, one heartbeat at a time.
Our MedTech platform focuses on developing cutting-edge medical technologies that improve patient outcomes and quality of life. With multiple smart, AI-powered wearable health diagnostic devices, our portfolio of products is designed to meet the evolving needs of healthcare providers and patients alike.
Topia Life Sciences developed the world's first medical grade, AI-based wearable long-term ECG skin patch to detect Arrhythmia through predictive analytics. The novel ECG skin patch includes a biocompatible polymer which captures the electrical signal through a flexible, printed, electronic conducting ink and a substrate which detects Arrhythmia with the R-R interval time series to obtain heart rate variability. The IoT-connected signal transmission is capable of recording and transferring the data through wireless communication which Topia's novel AI engine analyses, evaluates, tests and provides the data packets of Arrhythmia through a peak detector algorithm.
"Through the advancement of our platforms, we will build a fully integrated data economy. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world." - Kamlesh Patel, Founder